Be part of the knowledge.™

General Medicine and Primary Care

874

LikeLikedUnlike

91-105 of 134

Overcoming Clinical Inertia in Hyperkalemia Management
CME/CE
Overcoming Clinical Inertia in Hyperkalemia Management
- Peter Rossing, MD, DMSc
  Peer
- Michael Böhm, MD, FESC
  Peer
- Luca De Nicola, MD, PhD
  Peer
0.25 credits
MinuteCE®
The Future of ADH1 - Looking at Emergent Treatments
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 credits 4 episodes
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
MinuteCE®
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
CASR and ADH1: Integrating Biology and Genetic Screening
MinuteCE®
CASR and ADH1: Integrating Biology and Genetic Screening
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
Therapeutic Options for ADH1 and Hypoparathyroidism
MinuteCE®
Therapeutic Options for ADH1 and Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
Emerging Therapeutics in ADH1: Progress in Precision Medicine
MinuteCE®
Emerging Therapeutics in ADH1: Progress in Precision Medicine
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
advertisement
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
CME/CE
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
- Scott Kahan, MD, MPH
  Peer
- Ken Fujioka, MD
  Peer
- Carol Wysham
  Peer
0.50 credits
Hyperkalemia in CKD and HFrEF…What Am I Missing?
CME/CE
Hyperkalemia in CKD and HFrEF…What Am I Missing?
- George Bakris
  Peer
- David Bushinsky, MD
  Peer
- Lars Lund, MD
  Peer
0.25 credits
Advances in Minimally Invasive Screening for Lung Cancer
CME/CE
Advances in Minimally Invasive Screening for Lung Cancer
- Julie A. Barta, MD, ATSF
  Peer
- Peter J. Mazzone, MD, MPH, FCCP
  Peer
0.25 credits
MinuteCE®
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
- Richard Johnson, MD
  Peer
- Abdul Abdellatif, MD, FASN
  Peer
- John K. Botson, MD, RPh
  Peer
- Brittany Weber, MD, PhD
  Peer
Gout Beyond the Joints: What’s the Hidden Danger?
MinuteCE®
Gout Beyond the Joints: What’s the Hidden Danger?
- Richard Johnson, MD
  Peer
Is Gout Hiding in the Nephrology Clinic?
MinuteCE®
Is Gout Hiding in the Nephrology Clinic?
- Abdul Abdellatif, MD, FASN
  Peer
- Richard Johnson, MD
  Peer
advertisement
Is Managing Gout in the Nephrology Clinic a Challenge?
MinuteCE®
Is Managing Gout in the Nephrology Clinic a Challenge?
- Richard Johnson, MD
  Peer
- Abdul Abdellatif, MD, FASN
  Peer
Center of the Target: Which Patients Are Most Likely to Develop Gout?
MinuteCE®
Center of the Target: Which Patients Are Most Likely to Develop Gout?
- Richard Johnson, MD
  Peer
- Abdul Abdellatif, MD, FASN
  Peer
Treat or Refer: Who Is Responsible for Managing Gout?
MinuteCE®
Treat or Refer: Who Is Responsible for Managing Gout?
- John K. Botson, MD, RPh
  Peer
- Abdul Abdellatif, MD, FASN
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended